E-MAIL UPDATES

Click here to join
our Electronic Communications.

At the cutting edge

At the
cutting edge.

Research for life

Research
for life.

Innovation and performance

Innovation and
performance.

Latest

Whats new.

March 27th 2020
analyst reports

March 26th 2020
analyst reports

This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.

March 26th 2020
analyst reports

March 25th 2020
press releases

March 20th 2020
press releases

March 9th 2020
press releases
more

Upcoming Events

Whats next.

April 24th 2020 - April 29th 2020

read more
May 7th 2020 - May 9th 2020

read more
May 21st 2020 - May 22nd 2020

read more

Who we are

About us.

passion.

It takes a great deal of passion on the fight against cancer. We put our heart and soul into winning it.

know-how.

Our goal is to gather the strongest forces, the brightest minds and the most dedicated employees.

research.

Accurate research is the strong foundation for developing potential in effective treatment.

What is LAG3?
Lymphocyte-activation gene 3, or LAG-3 (LAG3), is a cell surface molecule with biologic effects on T cell function.
LAG3 is being used for many cancer immunotherapy treatments including Eftilagimod Alpha from Immutep.